nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—SERPINC1—Intrinsic Pathway—KNG1—peripheral nervous system neoplasm	0.0129	0.165	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—CD55—peripheral nervous system neoplasm	0.0125	0.16	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—KNG1—peripheral nervous system neoplasm	0.00872	0.111	CbGpPWpGaD
Fondaparinux sodium—F10—Intrinsic Pathway—KNG1—peripheral nervous system neoplasm	0.0073	0.0934	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—CD55—peripheral nervous system neoplasm	0.00708	0.0905	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—KNG1—peripheral nervous system neoplasm	0.00587	0.0751	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—KNG1—peripheral nervous system neoplasm	0.00585	0.0749	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—KNG1—peripheral nervous system neoplasm	0.00492	0.063	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—KNG1—peripheral nervous system neoplasm	0.00332	0.0424	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.00114	0.0145	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—KNG1—peripheral nervous system neoplasm	0.00105	0.0135	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—GNAS—peripheral nervous system neoplasm	0.00092	0.0118	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—HGF—peripheral nervous system neoplasm	0.000876	0.0112	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000641	0.0082	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000639	0.00818	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000594	0.0076	CbGpPWpGaD
Fondaparinux sodium—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000543	0.000589	CcSEcCtD
Fondaparinux sodium—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000543	0.000589	CcSEcCtD
Fondaparinux sodium—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000542	0.000588	CcSEcCtD
Fondaparinux sodium—Headache—Tretinoin—peripheral nervous system neoplasm	0.000542	0.000588	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00054	0.000586	CcSEcCtD
Fondaparinux sodium—Constipation—Vincristine—peripheral nervous system neoplasm	0.00054	0.000586	CcSEcCtD
Fondaparinux sodium—Pain—Vincristine—peripheral nervous system neoplasm	0.00054	0.000586	CcSEcCtD
Fondaparinux sodium—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.00054	0.000586	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00054	0.000586	CcSEcCtD
Fondaparinux sodium—Rash—Melphalan—peripheral nervous system neoplasm	0.000539	0.000584	CcSEcCtD
Fondaparinux sodium—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000538	0.000584	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000536	0.000582	CcSEcCtD
Fondaparinux sodium—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000534	0.000579	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000533	0.00681	CbGpPWpGaD
Fondaparinux sodium—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000533	0.000578	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000531	0.000576	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00053	0.000575	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000526	0.00057	CcSEcCtD
Fondaparinux sodium—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000522	0.000566	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000521	0.000565	CcSEcCtD
Fondaparinux sodium—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000521	0.000565	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—GNAS—peripheral nervous system neoplasm	0.00052	0.00665	CbGpPWpGaD
Fondaparinux sodium—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000518	0.000562	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000518	0.000562	CcSEcCtD
Fondaparinux sodium—Nausea—Topotecan—peripheral nervous system neoplasm	0.000518	0.000562	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000517	0.000561	CcSEcCtD
Fondaparinux sodium—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000517	0.000561	CcSEcCtD
Fondaparinux sodium—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000516	0.00056	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000515	0.000559	CcSEcCtD
Fondaparinux sodium—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000514	0.000558	CcSEcCtD
Fondaparinux sodium—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000514	0.000558	CcSEcCtD
Fondaparinux sodium—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000514	0.000557	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000512	0.000555	CcSEcCtD
Fondaparinux sodium—Infection—Etoposide—peripheral nervous system neoplasm	0.000509	0.000552	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000551	CcSEcCtD
Fondaparinux sodium—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000507	0.00055	CcSEcCtD
Fondaparinux sodium—Nausea—Melphalan—peripheral nervous system neoplasm	0.000507	0.00055	CcSEcCtD
Fondaparinux sodium—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000506	0.000549	CcSEcCtD
Fondaparinux sodium—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000505	0.000547	CcSEcCtD
Fondaparinux sodium—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000502	0.000545	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000502	0.000544	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000501	0.000544	CcSEcCtD
Fondaparinux sodium—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.0005	0.000542	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.0005	0.000542	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.0005	0.000542	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000498	0.00054	CcSEcCtD
Fondaparinux sodium—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000497	0.000539	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—HGF—peripheral nervous system neoplasm	0.000495	0.00633	CbGpPWpGaD
Fondaparinux sodium—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000495	0.000537	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000492	0.000533	CcSEcCtD
Fondaparinux sodium—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000488	0.000529	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.000528	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000486	0.000527	CcSEcCtD
Fondaparinux sodium—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000485	0.000526	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000484	0.000525	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000483	0.000524	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000482	0.000523	CcSEcCtD
Fondaparinux sodium—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000478	0.000519	CcSEcCtD
Fondaparinux sodium—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000478	0.000519	CcSEcCtD
Fondaparinux sodium—Pain—Cisplatin—peripheral nervous system neoplasm	0.000478	0.000518	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.000517	CcSEcCtD
Fondaparinux sodium—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000471	0.00051	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.00051	CcSEcCtD
Fondaparinux sodium—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.000506	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000466	0.000505	CcSEcCtD
Fondaparinux sodium—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000464	0.000503	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00046	0.0005	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00046	0.000499	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000456	0.000495	CcSEcCtD
Fondaparinux sodium—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000455	0.000494	CcSEcCtD
Fondaparinux sodium—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000453	0.000492	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00045	0.000488	CcSEcCtD
Fondaparinux sodium—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00045	0.000488	CcSEcCtD
Fondaparinux sodium—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00045	0.000488	CcSEcCtD
Fondaparinux sodium—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.000487	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000449	0.000487	CcSEcCtD
Fondaparinux sodium—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000446	0.000484	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000445	0.000483	CcSEcCtD
Fondaparinux sodium—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000442	0.00048	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000442	0.000479	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000442	0.000479	CcSEcCtD
Fondaparinux sodium—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000441	0.000479	CcSEcCtD
Fondaparinux sodium—Pain—Etoposide—peripheral nervous system neoplasm	0.000438	0.000475	CcSEcCtD
Fondaparinux sodium—Constipation—Etoposide—peripheral nervous system neoplasm	0.000438	0.000475	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000437	0.000474	CcSEcCtD
Fondaparinux sodium—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000434	0.00047	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000432	0.000469	CcSEcCtD
Fondaparinux sodium—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000429	0.000465	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000462	CcSEcCtD
Fondaparinux sodium—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000424	0.00046	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000422	0.000458	CcSEcCtD
Fondaparinux sodium—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00042	0.000456	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000419	0.000454	CcSEcCtD
Fondaparinux sodium—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000418	0.000453	CcSEcCtD
Fondaparinux sodium—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000417	0.000452	CcSEcCtD
Fondaparinux sodium—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000416	0.000452	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000416	0.000452	CcSEcCtD
Fondaparinux sodium—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000413	0.000449	CcSEcCtD
Fondaparinux sodium—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000413	0.000448	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000412	0.000447	CcSEcCtD
Fondaparinux sodium—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000411	0.000446	CcSEcCtD
Fondaparinux sodium—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000444	CcSEcCtD
Fondaparinux sodium—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000407	0.000441	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000406	0.00044	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000405	0.000439	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000405	0.000439	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.000439	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000404	0.000438	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000436	CcSEcCtD
Fondaparinux sodium—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000402	0.000436	CcSEcCtD
Fondaparinux sodium—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000401	0.000435	CcSEcCtD
Fondaparinux sodium—Rash—Vincristine—peripheral nervous system neoplasm	0.000398	0.000432	CcSEcCtD
Fondaparinux sodium—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000398	0.000432	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000398	0.000432	CcSEcCtD
Fondaparinux sodium—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000397	0.000431	CcSEcCtD
Fondaparinux sodium—Headache—Vincristine—peripheral nervous system neoplasm	0.000396	0.000429	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.000427	CcSEcCtD
Fondaparinux sodium—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.000426	CcSEcCtD
Fondaparinux sodium—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00039	0.000423	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000384	0.00492	CbGpPWpGaD
Fondaparinux sodium—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000382	0.000415	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000377	0.000409	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000407	CcSEcCtD
Fondaparinux sodium—Nausea—Vincristine—peripheral nervous system neoplasm	0.000375	0.000407	CcSEcCtD
Fondaparinux sodium—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000375	0.000407	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.000405	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000403	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.000399	CcSEcCtD
Fondaparinux sodium—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000367	0.000398	CcSEcCtD
Fondaparinux sodium—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000366	0.000398	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000396	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000395	CcSEcCtD
Fondaparinux sodium—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000362	0.000393	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000361	0.00462	CbGpPWpGaD
Fondaparinux sodium—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000391	CcSEcCtD
Fondaparinux sodium—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000355	0.000385	CcSEcCtD
Fondaparinux sodium—Rash—Cisplatin—peripheral nervous system neoplasm	0.000352	0.000382	CcSEcCtD
Fondaparinux sodium—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000352	0.000382	CcSEcCtD
Fondaparinux sodium—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000381	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00035	0.00038	CcSEcCtD
Fondaparinux sodium—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000376	CcSEcCtD
Fondaparinux sodium—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000376	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000374	CcSEcCtD
Fondaparinux sodium—Back pain—Epirubicin—peripheral nervous system neoplasm	0.00034	0.000369	CcSEcCtD
Fondaparinux sodium—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.000368	CcSEcCtD
Fondaparinux sodium—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000339	0.000367	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000366	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000365	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000362	CcSEcCtD
Fondaparinux sodium—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000332	0.00036	CcSEcCtD
Fondaparinux sodium—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000331	0.000359	CcSEcCtD
Fondaparinux sodium—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000325	0.000353	CcSEcCtD
Fondaparinux sodium—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000353	CcSEcCtD
Fondaparinux sodium—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000353	CcSEcCtD
Fondaparinux sodium—Rash—Etoposide—peripheral nervous system neoplasm	0.000323	0.00035	CcSEcCtD
Fondaparinux sodium—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000322	0.00035	CcSEcCtD
Fondaparinux sodium—Headache—Etoposide—peripheral nervous system neoplasm	0.000321	0.000348	CcSEcCtD
Fondaparinux sodium—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000348	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000346	CcSEcCtD
Fondaparinux sodium—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000343	CcSEcCtD
Fondaparinux sodium—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000342	CcSEcCtD
Fondaparinux sodium—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000341	CcSEcCtD
Fondaparinux sodium—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000337	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000335	CcSEcCtD
Fondaparinux sodium—Cough—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000333	CcSEcCtD
Fondaparinux sodium—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000333	CcSEcCtD
Fondaparinux sodium—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000305	0.00033	CcSEcCtD
Fondaparinux sodium—Nausea—Etoposide—peripheral nervous system neoplasm	0.000304	0.00033	CcSEcCtD
Fondaparinux sodium—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000326	CcSEcCtD
Fondaparinux sodium—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000325	CcSEcCtD
Fondaparinux sodium—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000324	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000297	0.000322	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—TP53—peripheral nervous system neoplasm	0.000294	0.00376	CbGpPWpGaD
Fondaparinux sodium—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000317	CcSEcCtD
Fondaparinux sodium—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000316	CcSEcCtD
Fondaparinux sodium—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000314	CcSEcCtD
Fondaparinux sodium—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000312	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000311	CcSEcCtD
Fondaparinux sodium—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000311	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.00031	CcSEcCtD
Fondaparinux sodium—Infection—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000309	CcSEcCtD
Fondaparinux sodium—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000308	CcSEcCtD
Fondaparinux sodium—Shock—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000306	CcSEcCtD
Fondaparinux sodium—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000306	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000305	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000281	0.0036	CbGpPWpGaD
Fondaparinux sodium—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000305	CcSEcCtD
Fondaparinux sodium—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000304	CcSEcCtD
Fondaparinux sodium—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000279	0.000302	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000301	CcSEcCtD
Fondaparinux sodium—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.0003	CcSEcCtD
Fondaparinux sodium—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000299	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000298	CcSEcCtD
Fondaparinux sodium—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000297	CcSEcCtD
Fondaparinux sodium—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000291	CcSEcCtD
Fondaparinux sodium—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.00029	CcSEcCtD
Fondaparinux sodium—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000288	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000288	CcSEcCtD
Fondaparinux sodium—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000286	CcSEcCtD
Fondaparinux sodium—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000283	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000282	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000282	CcSEcCtD
Fondaparinux sodium—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000282	CcSEcCtD
Fondaparinux sodium—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000281	CcSEcCtD
Fondaparinux sodium—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.00028	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000258	0.00028	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000278	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000278	CcSEcCtD
Fondaparinux sodium—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000277	CcSEcCtD
Fondaparinux sodium—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000275	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000274	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000271	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000248	0.00318	CbGpPWpGaD
Fondaparinux sodium—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000269	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000269	CcSEcCtD
Fondaparinux sodium—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000268	CcSEcCtD
Fondaparinux sodium—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000266	CcSEcCtD
Fondaparinux sodium—Pain—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000266	CcSEcCtD
Fondaparinux sodium—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000261	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000259	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000257	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000257	CcSEcCtD
Fondaparinux sodium—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000256	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000255	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000254	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.00025	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000249	CcSEcCtD
Fondaparinux sodium—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000248	CcSEcCtD
Fondaparinux sodium—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000247	CcSEcCtD
Fondaparinux sodium—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000246	CcSEcCtD
Fondaparinux sodium—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000246	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000246	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000246	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000237	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000217	0.00278	CbGpPWpGaD
Fondaparinux sodium—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000236	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000229	CcSEcCtD
Fondaparinux sodium—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000229	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000228	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000228	CcSEcCtD
Fondaparinux sodium—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000223	CcSEcCtD
Fondaparinux sodium—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000203	0.00022	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000213	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000212	CcSEcCtD
Fondaparinux sodium—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000207	CcSEcCtD
Fondaparinux sodium—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000206	CcSEcCtD
Fondaparinux sodium—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000204	CcSEcCtD
Fondaparinux sodium—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000198	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000197	CcSEcCtD
Fondaparinux sodium—Rash—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000196	CcSEcCtD
Fondaparinux sodium—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000196	CcSEcCtD
Fondaparinux sodium—Headache—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000195	CcSEcCtD
Fondaparinux sodium—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.00019	CcSEcCtD
Fondaparinux sodium—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000185	CcSEcCtD
Fondaparinux sodium—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000183	CcSEcCtD
Fondaparinux sodium—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000182	CcSEcCtD
Fondaparinux sodium—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000181	CcSEcCtD
Fondaparinux sodium—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.00018	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—TP53—peripheral nervous system neoplasm	0.000166	0.00213	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000159	0.00203	CbGpPWpGaD
Fondaparinux sodium—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000171	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—AKT1—peripheral nervous system neoplasm	0.00014	0.00179	CbGpPWpGaD
